Metraipolis › archive › dc_fea996beb40c
miR-199a-5p inhibits malignant progression and enhances cisplatin sensitivity of nasopharyngeal carcinoma by targeting SLC1A5 — Europe PMC PMID:41317550
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41317550
- DOI
- 10.1016/j.bjorl.2025.101739
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T04:47:07.206Z
- SHA-256 of the archived text
045f8f64c7ff851b1dd546f11f9c6941d323f79cf4458d3fcb70420d72ca34f6- Stable URL of this page
https://metraipolis.com/documento/dc_fea996beb40c
How to cite
miR-199a-5p inhibits malignant progression and enhances cisplatin sensitivity of nasopharyngeal carcinoma by targeting SLC1A5 — Europe PMC PMID:41317550 — Europe PMC (en), https://europepmc.org/article/MED/41317550 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fea996beb40c (Metraipolis archive dc_fea996beb40c, sha256 045f8f64c7ff851b1dd546f11f9c6941d323f79cf4458d3fcb70420d72ca34f6)
BibTeX
@misc{dcfea996beb40c,
title = {miR-199a-5p inhibits malignant progression and enhances cisplatin sensitivity of nasopharyngeal carcinoma by targeting SLC1A5 — Europe PMC PMID:41317550},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41317550},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fea996beb40c; sha256 045f8f64c7ff851b1dd546f11f9c6941d323f79cf4458d3fcb70420d72ca34f6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41317550. Agents can read the archived copy with the MCP tool read_document.